XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Mar. 31, 2019 1,266,950        
Beginning balance, value at Mar. 31, 2019 $ 1,267 $ 108,076,275 $ (105,652,433) $ (126,031) $ 2,299,078
Issuances of common stock for cash under at the market program, shares 3,087        
Issuances of common stock for cash under at the market program, value $ 3 36,619 36,622
Loss on debt extinguishment 447,011 447,011
Issuance of common shares upon vesting of restricted stock units, shares 3,539        
Issuance of common shares upon vesting of restricted stock units, value $ 4 (23,775) (23,771)
Stock based compensation expense 326,536 326,536
Net loss (2,066,424) (860) (2,067,284)
Ending balance, shares at Jun. 30, 2019 1,273,571        
Ending balance, value at Jun. 30, 2019 $ 1,274 108,862,666 (107,718,857) (126,891) 1,018,192
Issuances of common stock for cash under at the market program, shares 59,340        
Issuances of common stock for cash under at the market program, value $ 60 386,552 386,612
Issuance of common shares upon vesting of restricted stock units, shares 3,236        
Issuance of common shares upon vesting of restricted stock units, value $ 3 (8,448) (8,445)
Issuance of common shares upon warrant exchanges, shares 1,078        
Issuance of common shares upon warrant exchanges, value $ 1 4,402 4,403
Stock based compensation expense 326,536 326,536
Net loss (1,705,037) (1,589) (1,706,626)
Ending balance, shares at Sep. 30, 2019 1,337,259        
Ending balance, value at Sep. 30, 2019 $ 1,338 109,571,708 (109,423,894) (128,480) 20,672
Beginning balance, shares at Mar. 31, 2020 9,366,873        
Beginning balance, value at Mar. 31, 2020 $ 9,368 121,426,563 (112,026,381) (132,124) 9,277,426
Issuances of common stock for cash under at the market program, shares 2,685,600        
Issuances of common stock for cash under at the market program, value $ 2,686 7,258,183 7,260,869
Issuance of common shares upon vesting of restricted stock units, shares 17,920        
Issuance of common shares upon vesting of restricted stock units, value $ 18 (24,269) (24,251)
Stock based compensation expense 84,207 84,207
Net loss (1,410,283) (863) (1,411,146)
Ending balance, shares at Jun. 30, 2020 12,070,393        
Ending balance, value at Jun. 30, 2020 $ 12,072 128,744,684 (113,436,664) (132,987) 15,187,105
Issuance of common shares upon vesting of restricted stock units, shares 17,920        
Issuance of common shares upon vesting of restricted stock units, value $ 17 (16,145) (16,128)
Stock based compensation expense 167,042   167,042
Net loss (1,770,564) (825) (1,771,389)
Ending balance, shares at Sep. 30, 2020 12,088,313        
Ending balance, value at Sep. 30, 2020 $ 12,089 $ 128,895,581 $ (115,207,228) $ (133,812) $ 13,566,630